As of 2025-09-16, the Relative Valuation of Surmodics Inc (SRDX) is (41.76) USD. This relative valuation is based on P/E multiples. With the latest stock price at 32.37 USD, the upside of Surmodics Inc based on Relative Valuation is -229.0%.
The range of the Relative Valuation is (34.29) - (42.72) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 27.8x - 41.4x | 36.4x |
| Forward P/E multiples | 27.3x - 34.7x | 31.4x |
| Fair Price | (34.29) - (42.72) | (41.76) |
| Upside | -205.9% - -232.0% | -229.0% |
| Date | P/E |
| 2025-09-12 | -25.93 |
| 2025-09-11 | -26.18 |
| 2025-09-10 | -26.06 |
| 2025-09-09 | -26.65 |
| 2025-09-08 | -26.71 |
| 2025-09-05 | -26.27 |
| 2025-09-04 | -27.09 |
| 2025-09-03 | -27.61 |
| 2025-09-02 | -27.86 |
| 2025-08-29 | -27.62 |
| 2025-08-28 | -27.85 |
| 2025-08-27 | -27.70 |
| 2025-08-26 | -28.14 |
| 2025-08-25 | -28.65 |
| 2025-08-22 | -30.17 |
| 2025-08-21 | -29.28 |
| 2025-08-20 | -29.94 |
| 2025-08-19 | -30.29 |
| 2025-08-18 | -29.93 |
| 2025-08-15 | -30.39 |
| 2025-08-14 | -30.54 |
| 2025-08-13 | -30.82 |
| 2025-08-12 | -30.76 |
| 2025-08-11 | -30.83 |
| 2025-08-08 | -28.73 |
| 2025-08-07 | -28.40 |
| 2025-08-06 | -28.42 |
| 2025-08-05 | -28.73 |
| 2025-08-04 | -28.91 |
| 2025-08-01 | -29.23 |
| 2025-07-31 | -29.12 |
| 2025-07-30 | -30.37 |
| 2025-07-29 | -30.34 |
| 2025-07-28 | -29.74 |
| 2025-07-25 | -29.21 |
| 2025-07-24 | -26.00 |
| 2025-07-23 | -26.32 |
| 2025-07-22 | -25.88 |
| 2025-07-21 | -25.29 |
| 2025-07-18 | -24.51 |
| 2025-07-17 | -24.84 |
| 2025-07-16 | -25.32 |
| 2025-07-15 | -25.42 |
| 2025-07-14 | -25.47 |
| 2025-07-11 | -25.04 |
| 2025-07-10 | -25.17 |
| 2025-07-09 | -25.02 |
| 2025-07-08 | -24.35 |
| 2025-07-07 | -24.06 |
| 2025-07-03 | -24.33 |